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ABSTRACT
Background and Objectives: Patients without previous history of cardiac disease can be regarded as low-risk when under-
going major non-cardiac surgery. The aim of this study was to examine whether preoperative B-type natriuretic peptide 
(BNP) level predicted postoperative cardiac events in these patients. Subjects and Methods: Preoperative BNP level was 
measured in 163 patients whose risk was considered low according to the Revised Cardiac Risk Index. Postoperative cardiac 
events, including death during hospitalization, myocardial injury, arrhythmia, cerebrovascular accidents and congestive heart 
failure were assessed. Results: Postoperative cardiac events occurred in 8 patients (4.9%). Preoperative BNP levels were signifi-
cantly higher among patients who experienced postoperative cardiac events, compared to those who did not (130.6±148.8 vs. 
57.9±70.8 pg/mL, p=0.009). Conclusion: Preoperative BNP level may provide prognostic information in low-risk patients 
undergoing major non-cardiac surgery. (Korean Circ J 2011;41:11-15)
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Introduction
Perioperative mortality and morbidity associated with ma-
jor non-cardiac surgery are strongly related to cardiac complic-
ations, such as myocardial infarction, stroke, unstable angina, 
pulmonary edema and serious arrhythmia. Many studies have 
identified clinical predictors of adverse cardiac events, includ-
ing age, type of surgery, diabetes, congestive heart failure and 
previous history of angina or myocardial infarction.
1-3) Poor 
left ventricular (LV) systolic dysfunction is also a known pre-
dictor of perioperative cardiac events.
4)
If a cardiology consultation is requested for patients with kn-
own cardiac disease, intensive cardiac assessment may be per-
formed according to the guidelines on perioperative cardio-
vascular evaluation.
5) However, the evaluation steps or tools 
for risk stratification in patients with other risk factors, such 
as old age, diabetes and scheduled major non-cardiac surgery, 
which carries a 1-5% risk of cardiac events, have not been 
comprehensively studied. Moreover, symptoms of heart dis-
ease may be absent or blunted, especially in elderly or diabetic 
patients, and clinical evaluation alone may not be sufficient 
to stratify risks. Biomarkers readily available for testing, may 
assist with risk stratification and guide surgeons and patients 
in their evaluation surgical risks. 
B-type natriuretic peptide (BNP) levels correlate with prog-
nosis in patients with cardiac disease
6-9) and may be useful in 
risk stratification of patients undergoing non-cardiac sur-
gery.
10-14) Left ventricular systolic dysfunction is correlated with 
elevated BNP levels, and is a known predictor of periopera-
tive cardiac events. 
The purpose of this study was to assess whether BNP levels 
predicted perioperative cardiac events in patients who had no 
previous history of cardiac diseases, such as congestive heart 
failure, angina, or myocardial infarction.12   BNP as a Predictor of Perioperative Cardiac Events
Subjects and Methods
The study was a prospective, single-center, observational co-
hort study of consecutive patients undergoing major sched-
uled non-cardiac surgery. Major non-cardiac surgery was de-
fined as major gastrointestinal surgery (laparotomy, thoraco-
laparotomy), major orthopedic surgery and other major open 
surgery (gynecologic and urologic surgery). The risk of cardi-
ac events was calculated using the Lee’s Cardiac Risk Index, 
which is a standardized, validated clinical scoring system bas-
ed on the presence of 6 clinical variables: high-risk surgery, 
history of ischemic heart disease, congestive heart failure, ce-
rebrovascular disease, insulin therapy for diabetes mellitus 
and preoperative serum creatinine >2mg/dL.
15) Patients with a 
risk index score of 0 or 1 have complication rates of 0.4-0.9%. 
Such patients were regarded as low-risk. Exclusion criteria in-
cluded previous history of congestive heart failure, angina, or 
myocardial infarction, LV ejection fraction less than 50% and 
creatinine level ≥2.0 mg/dL.
Data collection
Preoperative data collection included a 12-lead electrocar-
diography (ECG) recording, echocardiography, clinical char-
acteristics, medical and surgical history, preoperative medica-
tions and renal and hepatic functions. Preoperative blood 
samples were also obtained for plasma BNP levels. The mean 
time of venous sampling before surgery was 3±8 days. All pa-
tients underwent standard 2-dimensional and doppler echo-
cardiographic examination with assessment of ventricular sys-
tolic and diastolic function. 
The left atrial (LA) volume was calculated using the formula 
for an ellipsoid: 
LA volume (mL)=Π/6 (D1×D2×D3)
where D1, D2, and D3 are the parasternal long axis, supero-
inferior, and medio-lateral measurements, respectively, of the 
LA at end-systole. The LA volume index was calculated as 
LA volume/body surface area. LV mass was calculated using 
guidelines recommended by the American Society of Echo-
cardiography, and left ventricular mass index (LVMI) was 
calculated as LV msss/body surface area.
Postoperative data collection included a 12-lead ECG re-
cording, chest radiograph, symptoms suggestive of myocar-
dial ischemia or congestive heart failure after surgery and dea-
th during hospitalization. 
Study end-points
The composite end-point was death, postoperative myo-
cardial injury {cardiac troponin I (cTnI) >0.32 ng/mL
-1, with-
out preoperative cTnI elevation}, ECG evidence of acute myo-
cardial ischemia or arrhythmia, cerebrovascular accident and 
congestive heart failure. ECG evidence of ischemia was de-
fined as the development of new, postoperative T-wave in-
version 2 mm and ST segment deviation 2 mm in at least two 
contiguous chest leads, or 1 mm in at least two contiguous 
limb leads. Arrhythmia was defined as a new, sustained, abnor-
mal cardiac rhythm. Congestive heart failure was diagnosed 
by physical examination and chest radiograph.
Assays
Plasma BNP was measured using the Bayer ADVIA Cen-
taur
TM immunoassay (Bayer Healthcare LLC, Diagnostic Di-
vision, Leverkusen, Germany) before an operation. 
Statistical analyses
Continuous data with a normal distribution are expressed 
as mean±standard deviation, and were compared using the 
Student’s t-test. Categorical data are presented as percentage 
frequencies, and differences between proportions were com-
pared using the chi-square test with Yates’ correction. Receiv-
er-operating characteristic (ROC) curve analysis was perform-
ed to calculate sensitivity, specificity and the area under the cur-
ve to select a cut-off value to predict perioperative cardiovas-
cular events. Multivariate analysis was conducted to determine 
factors related to perioperative cardiovascular complications. 
The variables were selected according to significant univari-
ate analysis, and odds ratios were given with 95% confidence 
intervals (CI). For continuous variables, the median value was 
used as a cut-off point to determine perioperative adverse events.
For all tests, a p less than 0.05 (2-tailed) was considered sta-
tistically significant. All analyses were performed using Sta-
tistical Package for the Social Sciences (SPSS) version 13.0 
statistical software (SPSS, Inc., Chicago, IL, USA).
Results
Patient characteristics
One hundred sixty-three patients met the inclusion crite-
ria for the study. Table 1 describes the clinical characteristics 
of the study population. The mean patient age was 71 years 
old. The age of patients with cardiac events was significantly 
higher than that of patients without cardiac events (77±8 vs. 
70±11, p=0.047). 
Postoperative events
Postoperative cardiac events occurred in 8 patients (4.9%): 
5 congestive heart failures, 1 myocardial injury, 2 unstable an-
ginas and 2 strokes. There was no cardiac death.
Plasma B-type natriuretic peptide concentrations
The mean preoperative BNP level was 61.5±77.2 pg/mL. 
Preoperative BNP levels were significantly higher among pa-
tients who experienced postoperative cardiac events (Table 1) 
(Fig. 1). Preoperative BNP predicted perioperative cardio-
vascular events with an area under the receiver operator char-Sung Eun Kim, et al.   13
acteristic curve of 0.76 (95% CI 0.63-0.89, p=0.014). The op-
timal cut-off point derived from this curve was 64.5 pg/mL. 
This had a sensitivity of 75% and a specificity of 75% (Fig. 2). 
Echocardiographic data
The mean LV ejection fraction was 61.5±6.7%. LA volume 
index was significantly higher in patients who experienced 
postoperative cardiac evenst than in patients who did not 
(33.3±23.0 vs. 22.1±7.1, p<0.0001) (Table 2).
Univariate and multivariate analysis
From univariate analysis, the presence of atrial fibrillation 
and LA volume index were significant predictors of postoper-
ative cardiac events. However, when preoperative BNP levels 
were included, the presence of atrial fibrillation and LA vol-
ume index were no longer statistically significant. BNP great-
er than 64.5 pg/mL did not reach statistical significance, but 
there was a trend for BNP to provide independent prognostic 
information (p=0.086). 
Table 1. Baseline clinical characteristics of the study cohort
Total patients
(n=163)
Patients with cardiac 
events (n=8)
Patients without cardiac
events (n=155)
p
Male (%) 56 (34.4) 2 (25.0) 54 (34.8) 0.568
Age (year) 071±11 77±8 070±11 0.047
Diabetes (%) 34 (20.9) 1 (12.5) 33 (21.3) 0.551
Hypertension (%) 83 (50.9) 4 (50.0) 79 (51.0) 0.957
Atrial fibrillation (%) 8 (4.9) 1 (14.3) 7 (4.5) 0.240
BMI (kg/m
2) 23.4±3.3 21.6±2.6 23.5±3.3 0.083
Cholesterol (mg/mL) 172.7±43.3 155.9±46.5 173.6±43.1 0.325
Creatinine (g/mL) 00.9±0.3 00.9±0.3 01.0±0.3 0.568
BNP (pg/mL) 061.5±77.2 0130.6±148.8 057.9±70.8 0.009
Surgical procedure (%) 0.657
Abdominal 46 (28.2) 3 (37.5) 43 (27.7)
Orthopedic 86 (52.8) 3 (37.5) 83 (53.5)
Others 31 (19.0) 2 (25.0) 29 (18.7)
BMI: body mass index, BNP: B-type natriuretic peptide
Fig. 1. A comparison of preoperative BNP levels in patients who 
experienced a postoperative cardiac event (Y) with those who did 
not (N). Central lines represent medians, boxes represent 25th 
and 75th percentiles and whiskers represent ranges. BNP: B-type 
natriuretic peptide.
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Fig. 2. Receiver operator characteristic curve for preoperative B-
type natriuretic peptide levels predicting an early postoperative car-
diac event. Area under the curve=0.76 (95% confidence interval= 
0.63-0.89, p=0.014). ROC: receiver-operating characteristic.
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Table 2. Baseline echocardiographic data of study cohort
Patients with 
cardiac events
(n=8)
Patients without 
cardiac events
(n=155)
p
LVEF (%) 58.7±7.3 61.7±6.6 0.338
LA (mm) 039.0±10.8 35.6±5.8 0.409
LAVI (mL/m
2) 042.0±31.7 22.3±7.3 <0.0001
LVM (g) 237.3±58.4 195.5±54.4 0.069
LVMI (g/m
2) 161.8±44.6 124.1±33.5 0.094
e/e’ 14.7±6.1 12.7±4.0 0.516
LVEF: left ventricular ejection fraction, LA: left atrium, LAVI: left 
ventricular volume index, LVM: left ventricular mass, LVMI: left 
ventricular mass index14   BNP as a Predictor of Perioperative Cardiac Events
 Discussion
Patients with no previous history of cardiac disease and nor-
mal LV systolic function can be regarded as low-risk for de-
veloping cardiac events during major non-cardiac surgery. In 
our study, however, a risk did exist (4.9%), although life-th-
reatening cardiac events did not happen. Preoperative BNP 
levels were higher in patients who suffered postoperative car-
diac events, which suggests that preoperative BNP level may 
provide prognostic information in patients no cardiac history. 
Prior studies
Efforts to identify patients at increased cardiac risks when 
undergoing non-cardiac surgery have led to the development 
of a variety of scoring systems.
1-3) In a multi-center study com-
paring several of these risk stratification indices, the areas un-
der the ROC curves ranged from 0.60 to 0.64.
16) Lee et al.
15) 
indicated that an area under the ROC curve of 0.76 for the 
ability of the Revised Cardiac Risk Index to identify patients 
who experience a postoperative cardiac event. Nevertheless, 
our data suggest that BNP has a useful role in risk prediction 
in this setting. We recognize, however, that the CI around the 
area under the ROC curve value of 0.63 was wide (0.59-0.83), 
and larger studies are required to provide more precise estimates.
 
B-type natriuretic peptide for the prediction 
of perioperative cardiac events
There are several reasons to support how BNP may predict 
cardiac events in this setting. BNP level is known to have pre-
dictive ability for cardiac events, such as heart failure, atrial fi-
brillation, stroke and coronary heart disease. Although a con-
centration of 100 pg/mL is widely accepted as the threshold 
to diagnose heart failure, excess risk exists at BNP levels well 
below this threshold.
7)17) We hypothesize that some patients 
scheduled for major surgery may have subclinical diastolic 
heart failure or ischemic heart disease. As such, preoperative 
BNP levels may reflect their underlying cardiovascular sta-
tus. In our study, the BNP level was lower than that reported in 
other studies, probably because all patients had an ejection 
fraction greater than 50%.
10)12)
Left atrial volume index and perioperative 
cardiac events
LA enlargement is traditionally considered a risk factor 
for atrial fibrillation, stroke and death in various clinical set-
tings.
18-21) Furthermore, it may be an early sign of hyperten-
sive heart disease in patients with no other discernible cause 
of LA enlargement.
22)23) Approximately 50% of our patients 
were hypertensive, so LA volume index may reflect their un-
derlying hypertensive heart disease status. However, the clini-
cal significance of this finding remains to be elucidated in fu-
ture studies.
Study limitations
This was a small study with limited statistical power. The 
lack of blinding substantially confounded the results because 
clinicians used the results of BNP measurements to manage 
patients. As such, treatment bias was unavoidable. Surgical 
complications or incidences related to surgical procedures can 
influence the occurrence of serious cardiac events. However, 
these were not taken into consideration. Finally, our cohort 
was heterogeneous. For instance, it included patients under-
going major abdominal surgery and hip surgery. Neverthe-
less, the predictive value of BNP concentration must demon-
strate sensitivity and specificity in such diverse clinical situ-
ations to prove its clinical usefulness. 
Conclusion
Pre-operative BNP levels were significantly higher among 
patients who experienced postoperative cardiac events than 
those who did not. Perioperative BNP levels may provide 
prognostic information on the risk of cardiac events in patients 
undergoing major non-cardiac surgery. 
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